Long-term clinical outcomes of micropulsed transcleral cyclophotocoagulation in open-angle glaucoma

Session Details

Session Title: Presented Poster Session: Glaucoma II

Venue: Poster Village: Pod 3

First Author: : B.Basarir TURKEY

Co Author(s): :    C. Altan   B. Solmaz   I. Pasaoglu   N. Alagoz   T. Yasar           

Abstract Details

Purpose:

The aim of this study is to describe our late outcomes with micropulse transscleral cyclophotocoagulation (MP-TSCPC) in patients with the diagnosis of moderate to severe open angle glaucoma (OAG).

Setting:

University of Heath Science Beyoglu Eye Training and Researh Hospital

Methods:

Patients with moderate to severe OAG who underwent MP-TSCPC with 810 nm infrared diod laser (IRIDEX IQ810 Laser Systems, CA) were included in this retrospective study.  The patients received sub-tenon anestesia prior to the procedure. Laser power was set at 2000 mW  on micropulse delivery mode. MicroPulse® P3 probe was applied in a “painting” motion along the upper and lower hemisphere avoiding the 3 and 9 o’clock positions. The laser was delivered for 80 seconds to each hemisphere for a total of 160 seconds.

Results:

Five eyes of five patients were included. Three eyes had severe glaucoma. The mean baseline intraocular pressure (IOP) was 22.2±4.2 mmHg and patients were on 2.4±1.5 topical glaucoma medications. Mean IOP was reduced by 30.6% from baseline at postoperative week 6, 41% at month 12 and 31% at month 18.  Mean IOP dropped to 15.4±1.1 mmHg at sixth week, 13,0±1.1 mmHg at 12 months and 15.3±3.0 at 18 months postoperatively.  Average medication use did not changed significantly at final postop visit. There were no serious adverse events. Only one patient underwent SLT at 15th months.

Conclusions:

Micropulsed transcleral diode laser seems to be a safe and effective treatment alternative to help lower IOP noninvasively in patients with OAG in early and also long term.

Financial Disclosure:

None